ACRS: Aclaris Therapeutics Company Short-Term Debt
The daily price chart for Aclaris Therapeutics (ACRS) reflects the dynamics of a company with a metric of 0.00. The business relies on the development of proprietary anti-inflammatory drugs, while alliances with industry behemoths strengthen its market position. Aclaris Therapeutics (ACRS) specializes in dermatology and immunology, utilizing exclusive molecules to establish high pricing power for the treatment of complex pathologies.
Metric breakdowns and analytics for Aclaris Therapeutics, Inc (ACRS)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Aclaris Therapeutics|ACRS - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Aclaris Therapeutics|ACRS - Company Total Debt|Debt to Book Capitalization Ratio Aclaris Therapeutics, Inc.|ACRS - Company Long-Term Liabilities|Company Current Liabilities Aclaris Therapeutics|Quick Liquidity aclaristx.com
- net income and valuation multiples indicators:
Initial company analysis:ACRS - Aclaris Therapeutics, Inc.
This indicator measures the aggregate of financial obligations due within twelve months, which is critical for assessing liquidity. An increase in this figure signals higher default risks in the event of cash flow gaps. By analyzing an organization's short-term debt via GURU.Markets, an investor can track borrowing trends. For Aclaris Therapeutics (ACRS), this parameter reflects the dependence of biotechnological developments on external financing. Monitoring this metric determines capital stability while awaiting trial results.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|Upstream Bio Corp - Company Short-Term Debts|ZBIO - Company Short-Term Debts|IMNM: Company Short-Term Debts|Company Current Liabilities gossamerbio.com|Company Short-Term Debt KalVista Pharmaceuticals, Inc.|Company Short-Term Debt SEPN|Company Short-Term Debts PVLA|Company Short-Term Debts Savara Pharma (SVRA)|Company Short-Term Debt Rigel Pharmaceuticals RIGL|Company Short-Term Loans and Borrowings ANAB|Astria Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt Volume enGene Holdings Inc ENGN|RAPT Therapeutics (RAPT) - Company Short-Term Debt|JBIO - Short-Term Debt Volume|Company Current Liabilities KYTX|TLSA: Company Short-Term Loans and Borrowings|Company Current Liabilities CABA (Cabaletta Bio)|Amount of Current Liabilities VTYX|Company Short-Term Debts THTX (Theratechnologies Inc)|Company Short-Term Loans and Borrowings AVTX|Eledon Pharmaceuticals - Company Short-Term Debts|Short-Term Debt agenusbio.com|Climb Bio (CLYM) - Company Short-Term Debt|zurabio.com - Company Short-Term Loans and Borrowings|ATYR (aTyr) - Company Short-Term Debts|Company Short-Term Debts Adagene Corp|Company Short-Term Debt ImageneBio Inc (IMA)|STTK: Current Liabilities|Company Short-Term Debts EQ (Equillium)|Connect Biopharma Holdings (CNTB) - Short-Term Debt|IMUX: Company Current Liabilities|ATRA - Company Short-Term Debts|IFRX (inflarx.de) - Company Current Liabilities|XFOR: Amount of Current Liabilities|ACET (Adicet Bio Inc.) - Company Short-Term Debts|Celularity Corp (CELU) - Short-Term Debt Volume|Company Short-Term Debts INMB|Company Current Liabilities Barinthus Biotherapeutics Corp BRNS|Company Short-Term Debt Kezar Life Sciences KZR|Short-Term Debt Volume sabbiotherapeutics.com (SABS)|Akari Therapeutics Plc - Company Short-Term Debts|ENLV - Company Short-Term Debts|QTTB: Company Short-Term Debts|Company Current Liabilities GeoVax Corp|Company Short-Term Debt Edesa Biotech, Inc.|IBIO: Company Short-Term Loans and Borrowings|Company Short-Term Debt Carisma Therapeutics (CARM)|Short-Term Debt Volume XTL Biopharmaceuticals Ltd|Company Short-Term Debt Bolt Biotherapeutics, Inc. BOLT|HCWB (HCW Biologics, Inc.) - Current Liabilities|Aptevo - Company Short-Term Debts|Company Short-Term Loans and Borrowings AIM (aimimmuno.com)|ADTX: Company Short-Term Debts|GRI Bio Inc (GRI) - Company Short-Term Debts|Company Short-Term Debt XORTX|HIND: Company Short-Term Loans and Borrowings|Company Short-Term Debt Revelation Biosciences (REVB)|Company Current Liabilities indaptusrx.com INDP|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|Company Short-Term Debts CalciMedica Inc CALI|AFMD: Company Current Liabilities|Company Short-Term Loans and Borrowings ALLK (Allakos Inc.)|HOOK: Company Short-Term Debts|IGMS - Short-Term Debt Volume|Company Short-Term Debt iTeos Therapeutics, Inc.|Company Current Liabilities Ocean Biomedical Inc (OCEA)|Company Short-Term Debt TC BioPharm (Holdings) PLC (TCBP)|Company Current Liabilities Third Harmonic Bio Inc THRD